Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $104.28 USD
Change Today +1.32 / 1.28%
Volume 1.0M
INCY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for incyte corp (INCY)

Year over year, Incyte Corporation has been able to grow revenues from $354.7M USD to $511.4M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 73.59% to 68.54%. This was a driver that led to an improvement in the bottom line from a loss of $83.1M USD to a smaller loss of $48.5M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 31
2012
Dec 31
2013
Dec 31
2014
4 Year
Trend
Revenues94.0296.6354.7511.4
Other Revenues0.50.50.20.1
TOTAL REVENUES94.5297.1354.9511.5
Cost of Goods Sold178.7210.5261.1350.5
GROSS PROFIT-84.386.593.9161.0
Selling General & Admin Expenses, Total58.285.4110.0165.8
OTHER OPERATING EXPENSES, TOTAL58.285.4110.0165.8
OPERATING INCOME-142.51.1-16.1-4.8
Interest Expense-43.8-46.1-38.7-46.8
Interest and Investment Income0.30.21.33.4
NET INTEREST EXPENSE-43.5-45.8-37.3-43.5
EBT, EXCLUDING UNUSUAL ITEMS-186.0-44.7-53.4-48.3
Gain (Loss) on Sale of Investments0.20.6----
Other Unusual Items, Total-0.7---29.4-0.3
Other Unusual Items-0.7---29.4-0.3
EBT, INCLUDING UNUSUAL ITEMS-186.5-44.1-82.8-48.5
Income Tax Expense--0.20.3-0.1
Earnings from Continuing Operations-186.5-44.3-83.1-48.5
NET INCOME-186.5-44.3-83.1-48.5
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-186.5-44.3-83.1-48.5
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-186.5-44.3-83.1-48.5
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $104.28 USD +1.32

INCY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $70.02 USD +2.49
ARIAD Pharmaceuticals Inc $8.16 USD +0.31
BioMarin Pharmaceutical Inc $146.27 USD +1.71
Jazz Pharmaceuticals PLC $192.24 USD +1.86
Vertex Pharmaceuticals Inc $135.00 USD -0.46
View Industry Companies
 

Industry Analysis

INCY

Industry Average

Valuation INCY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 30.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 29.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.